Holger Schmidt’s lab develops unique, highly sensitive devices to detect pathogen biomarkers.
CREDIT: Nick Gonzales
Sophisticated systems for the detection of biomarkers — molecules such as DNA or proteins that indicate the presence of a disease — are crucial for real-time diagnostic and disease-monitoring devices.
Holger Schmidt, distinguished professor of electrical and computer engineering at UC Santa Cruz, and his group have long been focused on developing unique, highly sensitive devices called optofluidic chips to detect biomarkers.
Schmidt’s graduate student Vahid Ganjalizadeh led an effort to use machine learning to enhance their systems by improving its ability to accurately classify biomarkers. The deep neural network he developed classifies particle signals with 99.8 percent accuracy in real time, on a system that is relatively cheap and portable for point-of-care applications, as shown in a new paper in Nature Scientific Reports.
When taking biomarker detectors into the field or a point-of-care setting such as a health clinic, the signals received by the sensors may not be as high quality as those in a lab or a controlled environment. This may be due to a variety of factors, such as the need to use cheaper chips to bring down costs, or environmental characteristics such as temperature and humidity.
To address the challenges of a weak signal, Schmidt and his team developed a deep neural network that can identify the source of that weak signal with high confidence. The researchers trained the neural network with known training signals, teaching it to recognize potential variations it could see, so that it can recognize patterns and identify new signals with very high accuracy.
First, a parallel cluster wavelet analysis (PCWA) approach designed in Schmidt’s lab detects that a signal is present. Then, the neural network processes the potentially weak or noisy signal, identifying its source. This system works in real time, so users are able to receive results in a fraction of a second.
“It’s all about making the most of possibly low quality signals, and doing that really fast and efficiently,” Schmidt said.
A smaller version of the neural network model can run on portable devices. In the paper, the researchers run the system over a Google Coral Dev board, a relatively cheap edge device for accelerated execution of artificial intelligence algorithms. This means the system also requires less power to execute the processing compared to other techniques.
“Unlike some research that requires running on supercomputers to do high-accuracy detection, we proved that even a compact, portable, relatively cheap device can do the job for us,” Ganjalizadeh said. “It makes it available, feasible, and portable for point-of-care applications.”
The entire system is designed to be used completely locally, meaning the data processing can happen without internet access, unlike other systems that rely on cloud computing. This also provides a data security advantage, because results can be produced without the need to share data with a cloud server provider.
It is also designed to be able to give results on a mobile device, eliminating the need to bring a laptop into the field.
“You can build a more robust system that you could take out to under-resourced or less- developed regions, and it still works,” Schmidt said.
This improved system will work for any other biomarkers Schmidt’s lab’s systems have been used to detect in the past, such as COVID-19, Ebola, flu, and cancer biomarkers. Although they are currently focused on medical applications, the system could potentially be adapted for the detection of any type of signal.
To push the technology further, Schmidt and his lab members plan to add even more dynamic signal processing capabilities to their devices. This will simplify the system and combine the processing techniques needed to detect signals at both low and high concentrations of molecules. The team is also working to bring discrete parts of the setup into the integrated design of the optofluidic chip.
More from: University of California Santa Cruz
The Latest Updates from Bing News
Go deeper with Bing News on:
Real-time diagnostic device
- Wearable Optical Device Helps Early Detection of Postpartum Hemorrhage
A new laser-assisted wearable optical device shows promises in early diagnosis and treatment ... Although wearable laser speckle imaging sensors have been developed for real-time monitoring of blood ...
- The Impact of AI-Powered Assistants on Healthcare: A Comprehensive Analysis
Artificial Intelligence (AI) has revolutionized numerous industries, and one of the most promising fields where AI is making a significant impact is healthcare. In recent years, AI-powered assistants ...
- Researchers develop wearable optical device for early detection of postpartum hemorrhage
Researchers have developed a wearable optical device for early detection of hemorrhage during labor or after childbirth.
- Wearable optical device shows promise for detecting postpartum hemorrhage
Researchers have developed a wearable optical device for early detection of hemorrhage during labor or after childbirth. This serious heavy bleeding can be hard to detect before it becomes an ...
- Optiscan on cusp of real-time cancer imaging breakthrough
Optiscan Imaging is on a mission to prove its technology can provide surgeons with the exact extent of breast cancer margins at the time of operating through the real-time diagnosis of affected ...
Go deeper with Bing News on:
- Comparing two plasma p-tau217 assays for Alzheimer's detection and monitoring
Researchers compared two commercially available blood tests based on the biomarker p-tau217 for diagnosing Alzheimer's disease in 294 patients. Both tests demonstrated robust diagnostic capabilities, ...
- Study discovers novel intracellular signaling mechanisms that promote melanoma growth
Investigators led by Kathleen Green, Ph.D., the Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology, have discovered novel intercellular "crosstalk" between epidermal keratinocytes and ...
- Meet the Two New Biomarker Candidates for Lewy Body Diseases
With several fluid biomarkers for Alzheimer’s in hand, the search is on for counterparts in Parkinson’s disease and dementia with Lewy bodies (DLB). Four new papers introduce two candidates: DOPA ...
- Researchers develop wearable sensor for continuous detection of solid-state biomarkers in skin
Researchers at Singapore’s Agency for Science Technology & Research Bioprocessing Technology Institute (also known as A*STAR BTI) saw publication of their patent application for a wearable electronic ...
- Multiplex Detection Immunoassays Market Revenue to Cross USD 3.6 billion by 2030, Rising at a 7.5% CAGR: TMR Report
Streamlining regulatory processes and obtaining approvals for new multiplex immunoassay products can lead to market expansion.Wilmington, Delaware, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) -- ...